146 related articles for article (PubMed ID: 9157985)
1. Enhanced therapeutic effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Ahmad I; Filep JJ; Franklin JC; Janoff AS; Masters GR; Pattassery J; Peters A; Schupsky JJ; Zha Y; Mayhew E
Cancer Res; 1997 May; 57(10):1915-21. PubMed ID: 9157985
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and growth inhibitory properties of glycosides of 1-O-hexadecyl-2-O-methyl-sn-glycerol, analogs of the antitumor ether lipid ET-18-OCH3 (edelfosine).
Marino-Albernas JR; Bittman R; Peters A; Mayhew E
J Med Chem; 1996 Aug; 39(17):3241-7. PubMed ID: 8765506
[TBL] [Abstract][Full Text] [Related]
3. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine.
Chabot MC; Wykle RL; Modest EJ; Daniel LW
Cancer Res; 1989 Aug; 49(16):4441-5. PubMed ID: 2743333
[TBL] [Abstract][Full Text] [Related]
4. Growth inhibitory effects of liposome-associated 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Peters AC; Ahmad I; Janoff AS; Pushkareva MY; Mayhew E
Lipids; 1997 Oct; 32(10):1045-54. PubMed ID: 9358430
[TBL] [Abstract][Full Text] [Related]
5. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues.
Powis G; Seewald MJ; Gratas C; Melder D; Riebow J; Modest EJ
Cancer Res; 1992 May; 52(10):2835-40. PubMed ID: 1316230
[TBL] [Abstract][Full Text] [Related]
6. Stability of association of 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine with liposomes is composition dependent.
Mayhew E; Ahmad I; Bhatia S; Dause R; Filep J; Janoff AS; Kaisheva E; Perkins WR; Zha Y; Franklin JC
Biochim Biophys Acta; 1997 Oct; 1329(1):139-48. PubMed ID: 9370251
[TBL] [Abstract][Full Text] [Related]
7. Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine.
Pushkareva MY; Wannberg SL; Janoff AS; Mayhew E
Cancer Immunol Immunother; 2000 Jan; 48(10):569-78. PubMed ID: 10630309
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues.
Berggren MI; Gallegos A; Dressler LA; Modest EJ; Powis G
Cancer Res; 1993 Sep; 53(18):4297-302. PubMed ID: 8395981
[TBL] [Abstract][Full Text] [Related]
9. Cell kill and cytostasis by ET-18-OCH3 and heat.
Fujiwara K; Modest EJ; Wallen CA
Anticancer Res; 1995; 15(4):1333-8. PubMed ID: 7654017
[TBL] [Abstract][Full Text] [Related]
10. Toxicity and disposition of TLC ELL-12 (liposomal antitumor ether lipid) in Sprague-Dawley rats.
Bhamra R; Bolcsak LE; Roberts P; Stevens R; Cavanaugh C; Swenson CE
Anticancer Drugs; 2003 Mar; 14(3):183-91. PubMed ID: 12634612
[TBL] [Abstract][Full Text] [Related]
11. Liposomal N,N,N-trimethylsphingosine (TMS) as an inhibitor of B16 melanoma cell growth and metastasis with reduced toxicity and enhanced drug efficacy compared to free TMS: cell membrane signaling as a target in cancer therapy III.
Park YS; Hakomori S; Kawa S; Ruan F; Igarashi Y
Cancer Res; 1994 Apr; 54(8):2213-7. PubMed ID: 8174128
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of the effects of the antitumour ether lipid ET-18-OCH3 on cytosolic calcium and on apoptosis.
Alonso MT; Gajate C; Mollinedo F; Modolell M; Alvarez J; García-Sancho J
Br J Pharmacol; 1997 Aug; 121(7):1364-8. PubMed ID: 9257915
[TBL] [Abstract][Full Text] [Related]
13. Decreased sensitivity to 1-O-octadecyl-2-O-methyl-glycerophosphocholine in MCF-7 cells adapted for serum-free growth correlates with constitutive association of Raf-1 with cellular membranes.
Samadder P; Arthur G
Cancer Res; 1999 Oct; 59(19):4808-15. PubMed ID: 10519389
[TBL] [Abstract][Full Text] [Related]
14. 9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.
Koshkina NV; Kleinerman ES; Waidrep C; Jia SF; Worth LL; Gilbert BE; Knight V
Clin Cancer Res; 2000 Jul; 6(7):2876-80. PubMed ID: 10914737
[TBL] [Abstract][Full Text] [Related]
15. The antitumor ether lipid 1-Q-octadecyl-2-O-methyl-rac-glycerophosphocholine (ET-18-OCH3) inhibits the association between Ras and Raf-1.
Samadder P; Richards C; Bittman R; Bhullar RP; Arthur G
Anticancer Res; 2003; 23(3B):2291-5. PubMed ID: 12894505
[TBL] [Abstract][Full Text] [Related]
16. Combination of antitumor ether lipid with lipids of complementary molecular shape reduces its hemolytic activity.
Perkins WR; Dause RB; Li X; Franklin JC; Cabral-Lilly DJ; Zha Y; Dank EH; Mayhew E; Janoff AS
Biochim Biophys Acta; 1997 Jul; 1327(1):61-8. PubMed ID: 9247167
[TBL] [Abstract][Full Text] [Related]
17. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
Lim HJ; Masin D; Madden TD; Bally MB
J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
[TBL] [Abstract][Full Text] [Related]
18. The relationship between cellular ether glycerophospholipid content and sensitivity of cancer cells to 1-O-octadecyl-2-O-methyl-glycerophosphocholine.
Zhou X; Lu X; Arthur G
Anticancer Res; 1992; 12(5):1659-62. PubMed ID: 1444233
[TBL] [Abstract][Full Text] [Related]
19. Cytokinetic and morphologic differences in ovarian cancer cells treated with ET-18-OCH3 and the DNA-interacting agent, etoposide.
Fujiwara K; Koike H; Ohishi Y; Shirafuji H; Kohno I; Modest EJ; Kataoka S
Anticancer Res; 1997; 17(3C):2159-67. PubMed ID: 9216681
[TBL] [Abstract][Full Text] [Related]
20. Antiinvasive effect of racemic 1-O-octadecyl-2-O-methylglycero-3-phosphocholine on MO4 mouse fibrosarcoma cells in vitro.
Storme GA; Berdel WE; van Blitterswijk WJ; Bruyneel EA; De Bruyne GK; Mareel MM
Cancer Res; 1985 Jan; 45(1):351-7. PubMed ID: 4038380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
